Denileukin Diftitox in Treating Patients With Fludarabine-Refractory B-Cell Chronic Lymphocytic Leukemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Arthur E. Frankel, MD
Wake Forest University Health Sciences
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- St. Joseph Hospital Regional Cancer Center - Orange
Orange, California, United States
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois, United States
- Medical Center Vincennes
Vincennes, Indiana, United States
- Cancer Care Specialists
Houma, Louisiana, United States
- Feist-Weiller Cancer Center at Louisiana State University Health Sciences
Shreveport, Louisiana, United States
- Josephine Ford Cancer Center at Henry Ford Health System
Detroit, Michigan, United States
- Southeastern Medical Oncology Center
Goldsboro, North Carolina, United States
- Comprehensive Cancer Center at Wake Forest University
Winston-Salem, North Carolina, United States
- Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
Spartanburg, South Carolina, United States
- Chattanooga Oncology and Hematology Associates
Chattanooga, Tennessee, United States
- Southwest Regional Cancer Center - Central
Austin, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2002
- Primary completion
- 31 Jan 2005
- Completion
- 30 Jun 2005
- Last update posted
- 19 Jan 2017
- Registered enrollment
- —
- Registry id
- NCT00082940
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.